LUCAT1 and colorectal cancer: Additionally, LUCAT1+ monocytes were found to be more active in right-sided colorectal cancer, potentially influencing the glycosaminoglycan degradation pathway, thereby disrupting cell adhesion and facilitating tumor cell invasion.